<p>In this episode, we’re joined by Jenny Yang, Founder and CEO of Outpost Bio, a company building an AI-driven platform to understand how the human microbiome interacts with drugs, food, and other interventions.</p><p>Jenny shares her journey from machine learning and genomics research through to her PhD at the University of Oxford and experience at Exscientia, before founding Outpost Bio.</p><p>We discuss why the microbiome remains an underexplored layer in drug discovery, how advances in AI are enabling more complex biological modelling, and the role of high-quality data in building systems that can translate into real-world impact.</p><p></p>